Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06458127 · ClinicalTrials.gov registry record · NA

Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease

A NA study of Chronic Graft Versus Host Disease and cGVHD, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06458127 is a NA study of Chronic Graft Versus Host Disease and cGVHD that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 10 participants, below the 116-participant average among 30 other Chronic Graft Versus Host Disease trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06458127, a NA study of Chronic Graft Versus Host Disease and cGVHD, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This research study is evaluating the feasibility and acceptability of implementing a telehealth palliative care intervention in patients with moderate to severe chronic graft-versus-host disease.

Interventions

  • OTHER Tele-palliative care visit

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital (MGH) - Boston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2024-09-09
Est. Completion 2027-01-30
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06458127

The ClinicalTrials.gov registry entry for NCT06458127 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 116-participant average among 30 other Chronic Graft Versus Host Disease trials with a reported enrollment target (91% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Chronic Graft Versus Host Disease appearing as the primary indexed condition, and to 1 intervention - of which Tele-palliative care visit is the first listed.

NCT06458127 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06458127 about?

NCT06458127 is a clinical study titled "Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease". This research study is evaluating the feasibility and acceptability of implementing a telehealth palliative care intervention in patients with moderate to severe chronic graft-versus-host disease.

What is the current status of trial NCT06458127?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-09-09. Estimated completion is 2027-01-30.

What conditions does trial NCT06458127 study?

This clinical trial studies the following conditions: Chronic Graft Versus Host Disease, cGVHD, Chronic GVHD.

What interventions are being tested in trial NCT06458127?

The interventions under investigation include: Tele-palliative care visit (OTHER).

Who is sponsoring clinical trial NCT06458127?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06458127 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Graft Versus Host Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.